Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
5FU/LV
DRUG
2 trials
Sponsors
AHS Cancer Control Alberta
, The Methodist Hospital Research Institute
Conditions
Colon Cancer
Metastatic Colorectal Cancer (CRC)
Phase 2
5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
Recruiting
NCT06887218
The Methodist Hospital Research Institute
Metastatic Colorectal Cancer (CRC)
Start: 2025-05-08
End: 2029-12-31
Target: 57
Updated: 2025-08-27
Unknown Phase
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer
NCT00131599
AHS Cancer Control Alberta
Colon Cancer
Start: 2002-08-31
End: 2017-07-31
Target: 104
Updated: 2017-01-16